Recent studies suggest that with some caveats, patients with Fitzpatrick skin types IV to VI can achieve satisfactory results without serious adverse effects.
Investigators evaluated the safety and efficacy of an integrated cooling vacuum-assisted 1540-nm erbium:glass laser to treat acne.
Compared with baseline, significant reductions in noninflammatory, inflammatory, and total lesions were seen in the first 4 weeks of treatment with CL-BP 3.75%.
Tretinoin 0.05 percent lotion (ALTRENO Lotion) provides statistically significant improvement in patients with moderate-to-severe acne, compared to placebo.
Investigators conducted a systemic review to develop an international consensus recommendation for the management of patients with hidradenitis suppurativa.
The approval was based on data from 2 large, multicenter, randomized, double-blind, placebo-controlled Phase 3 trials involving patients with moderate to severe facial acne vulgaris.
Dermatology Advisor Articles
- Botulinum Toxin Type A Effective for Treating Rosacea Facial Flushing
- Acne Lesions, Scars Treated With Cooling Vacuum-Assisted Erbium:Glass Laser
- Psoriasis Linked With Higher Risk for Sexual Dysfunction
- New Psoriatic Arthritis Guidelines Recommend TNFi as First-Line Tx Option
- AMA Survey Collects Advice for Physicians Approaching Retirement
- Common Skin Conditions in People of Color: Identification and Treatment
- Subcutaneous Dupilumab Initiates Hair Regrowth in Patient With Alopecia Totalis, Atopic Dermatitis
- Rosacea Improves With Anti-Inflammatory Effect of Brimonidine Gel
- Can Examining Marginalization Identify Gaps in Medical or Nutritional Care?
- Mohs Surgery Alone Associated With Improved Outcomes in High-Risk Squamous Cell Carcinoma
- Secukinumab Superior to Placebo for Treatment of Moderate to Severe Nail Psoriasis
- Diagnostic Challenges of Neutrophilic Dermatosis May Lead to Misdiagnosis
- EMS Times Longer for Patients From Poorest Neighborhoods
- Most Insured Patients Not Using Online Portals
- Overcoming the Barriers to Including Pregnant Women in Clinical Trials